FountainVest Partners’ US$900 Million Acquisition of Langdi Pharmaceutical

Goodwin Procter advised FountainVest Partners on the deal.FountainVest Partners announced the acquisition of China-based Beijing Zhendong Langdi Pharmaceutical Co., Ltd. for approximately US$900 million. FountainVest is now…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now